Story perspectives

England Launches Five-Session Precision Prostate Radiotherapy Nationwide

6/10/2026

Summary

Story summary

England will soon offer a five-session precision radiotherapy that reduces prostate cancer courses by three-quarters.
NHS England will deliver stereotactic ablative radiotherapy to low- and intermediate-risk patients at all 48 centres within weeks.
Patient Edwin Lambert, 70, reported fewer side effects and returned to an archaeological dig five weeks after treatment.
Modelling indicates about 3,500 of the 17,500 eligible men may choose the therapy while trials test it on high-risk patients.

1 of 1

Story summary

England will soon offer a five-session precision radiotherapy that reduces prostate cancer courses by three-quarters.
NHS England will deliver stereotactic ablative radiotherapy to low- and intermediate-risk patients at all 48 centres within weeks.
Patient Edwin Lambert, 70, reported fewer side effects and returned to an archaeological dig five weeks after treatment.
Modelling indicates about 3,500 of the 17,500 eligible men may choose the therapy while trials test it on high-risk patients.